Covetrus (NASDAQ:CVET) and (OTCMKTS:HEWA) are both computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, institutional ownership, profitability and dividends.

Insider and Institutional Ownership

70.8% of Covetrus shares are held by institutional investors. 24.5% of shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.


This table compares Covetrus and’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Covetrus N/A N/A N/A -3.08% N/A -15.53%

Valuation and Earnings

This table compares Covetrus and’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Covetrus $3.78 billion 0.75 $100.86 million N/A N/A $15.75 million 0.87 -$820,000.00 N/A N/A

Covetrus has higher revenue and earnings than

Analyst Ratings

This is a breakdown of current recommendations for Covetrus and, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Covetrus 0 4 3 0 2.43 0 0 0 0 N/A

Covetrus presently has a consensus target price of $36.67, indicating a potential upside of 45.39%. Given Covetrus’ higher probable upside, research analysts clearly believe Covetrus is more favorable than


Covetrus beats on 7 of the 9 factors compared between the two stocks.

Covetrus Company Profile

Covetrus, Inc. engages in developing technologies and services for animal health industry. It also provides products, software, and services to help drive improved patient health, strong client relationships, and successful financial outcomes for veterinary professionals. The company was founded on April 13, 2018 and is headquartered in Melville, NY. Company Profile, Inc. operates an online mail order pharmacy. The company markets a range of generic, brand name, and pet prescription medicines, as well as over-the-counter (OTC) medications and products. It sells its products in 50 states and the District of Columbia in the United States to focus on the out-of-pocket prescription drug market. The company sells prescription medications and OTC products to individual consumers over the Internet., Inc. is headquartered in Florence, Kentucky.

Receive News & Ratings for Covetrus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covetrus and related companies with's FREE daily email newsletter.